← All stocks

TScan Therapeutics, Inc.

TCRX Net buying

CIK 0001783328 #4673 in the set updated 21 Sep 2026

Bought (12 mo)

$145.53K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$145.53K

+$145.53K against sales at will

By person

2 insiders · 3 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Lynx1 Capital Management LP entity

10% owner

$145.53K (3)

—

+$145.53K

8,019,148

6.2%

$7.21M

+56.1%

Klencke Barbara

Director

—

45,000

0.035%

$40.45K

+12.5%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 12

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 2

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 16 Jul 2021